# Adèle Hesters

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/adele-hesters/

## Facts

| Field | Value |
| --- | --- |
| Citations | 891 |
| Field | Amyotrophic Lateral Sclerosis Research |
| h-index | 14 |
| i10-index | 15 |
| Last Known Institution | Valve (United States) |
| OpenAlex ID | https://openalex.org/A5109524260 |
| Works | 26 |

## Researcher papers

- [COVID‐19‐related encephalopathy: a case series with brain FDG‐positron‐emission tomography/computed tomography findings](https://scholariq.org/papers/covid-19-related-encephalopathy-a-case-series-with-brain-fdg-positron-emission/)
- [The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study](https://scholariq.org/papers/the-cerebral-network-of-covid-19-related-encephalopathy-a-longitudinal-voxel/)
- [Severe COVID-19-related encephalitis can respond to immunotherapy](https://scholariq.org/papers/severe-covid-19-related-encephalitis-can-respond-to-immunotherapy/)
- [Association of Clinical, Biological, and Brain Magnetic Resonance Imaging Findings With Electroencephalographic Findings for Patients With COVID-19](https://scholariq.org/papers/association-of-clinical-biological-and-brain-magnetic-resonance-imaging-findings/)
- [Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles](https://scholariq.org/papers/muscle-cells-of-sporadic-amyotrophic-lateral-sclerosis-patients-secrete/)
- [Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial](https://scholariq.org/papers/efficacy-and-safety-of-low-dose-il-2-as-an-add-on-therapy-to-riluzole-mirocals-a/)
- [The wide spectrum of COVID-19 neuropsychiatric complications within a multidisciplinary centre](https://scholariq.org/papers/the-wide-spectrum-of-covid-19-neuropsychiatric-complications-within-a/)
- [Dysregulation of muscle cholesterol transport in amyotrophic lateral sclerosis](https://scholariq.org/papers/dysregulation-of-muscle-cholesterol-transport-in-amyotrophic-lateral-sclerosis/)
- [Predictive factors for prognosis after gastrostomy placement in routine non-invasive ventilation users ALS patients](https://scholariq.org/papers/predictive-factors-for-prognosis-after-gastrostomy-placement-in-routine-non/)
- [Long-Term Tofersen in <i>SOD1</i> Amyotrophic Lateral Sclerosis](https://scholariq.org/papers/long-term-tofersen-in-i-sod1-i-amyotrophic-lateral-sclerosis/)
- [Care pathway heterogeneity in Amyotrophic Lateral Sclerosis: effects of gender, age and onset](https://scholariq.org/papers/care-pathway-heterogeneity-in-amyotrophic-lateral-sclerosis-effects-of-gender/)

## Researcher topics

- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)
- [Neurogenetic and Muscular Disorders Research](https://scholariq.org/topics/neurogenetic-and-muscular-disorders-research/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)

## Researcher university

- [Valve (United States)](https://scholariq.org/institutions/valve-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.